Ocular changes in patients undergoing long-term desferrioxamine treatment
about
Multiple transfused thalassemia major: ocular manifestations in a hospital-based population.Practical management of iron overload.Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.Macular vitelliform lesion in desferrioxamine-related retinopathy.Complications of thalassemia major and their treatment.Retinal abnormalities in β-thalassemia major.Iron-chelating therapy.Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage.Desferioximine induced Ototoxicity in Thalassemic patients.Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.Desferrioxamine (Desferal) and superoxide free radicals. Formation of an enzyme-damaging nitroxideQuantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major.Retinal nerve fiber layer thickness in children with β-thalassemia major.Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane.Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients.Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature
P2860
Q33788767-49350E7F-C971-4F5F-8083-EE555363DDEFQ34434629-61588823-ED27-41B7-BBD0-7A2762AAF120Q35881019-61D72BA5-5B60-4CD8-AE7E-417F0E6E1F42Q36948656-B71312B3-9D4B-4978-ACFC-8013AD23544DQ37888721-377AA9E2-E5BD-4E4D-9BF0-40657B29379EQ38577858-E77A8D6D-BB6A-4EC5-912B-09F02F616DC3Q39581560-EA380B14-B654-4552-8671-481BE137DB6BQ41779524-2D090DD5-3556-4BDA-97FE-868889E430A7Q41880406-9CC2BB66-85C0-4A25-87D9-4C795A5D2D7AQ42192916-BA2ACC13-B03C-4432-8019-19DA6FCB324DQ42759613-5440D6C7-ADDE-46D8-852B-8FE12433DCF2Q42835886-C26903E2-3832-49D2-8969-4B044DAC86B8Q42856800-916001CA-E6FC-4F6D-9EB8-6ADFC0D869C3Q44425422-B3CD6480-E49C-4CD5-A7CC-489B80546483Q47163080-A1A5680D-6AA5-491E-8E46-B807C8EEF8A2Q51806844-AAA7BA85-CCC4-4605-B0AA-789F9C22F1C8Q54063063-EFF1F331-3D06-41BD-97AC-34CB96D19002Q58748616-3FF3298F-49FB-4174-B446-7A19966E17E7
P2860
Ocular changes in patients undergoing long-term desferrioxamine treatment
description
1984 nî lūn-bûn
@nan
1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
name
Ocular changes in patients undergoing long-term desferrioxamine treatment
@ast
Ocular changes in patients undergoing long-term desferrioxamine treatment
@en
type
label
Ocular changes in patients undergoing long-term desferrioxamine treatment
@ast
Ocular changes in patients undergoing long-term desferrioxamine treatment
@en
prefLabel
Ocular changes in patients undergoing long-term desferrioxamine treatment
@ast
Ocular changes in patients undergoing long-term desferrioxamine treatment
@en
P2093
P2860
P356
P1476
Ocular changes in patients undergoing long-term desferrioxamine treatment
@en
P2093
P2860
P304
P356
10.1136/BJO.68.12.873
P407
P577
1984-12-01T00:00:00Z